Leonard Lothstein

1.8k total citations
37 papers, 1.6k citations indexed

About

Leonard Lothstein is a scholar working on Molecular Biology, Oncology and Toxicology. According to data from OpenAlex, Leonard Lothstein has authored 37 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 23 papers in Oncology and 6 papers in Toxicology. Recurrent topics in Leonard Lothstein's work include Drug Transport and Resistance Mechanisms (13 papers), Cancer therapeutics and mechanisms (13 papers) and Cancer Treatment and Pharmacology (7 papers). Leonard Lothstein is often cited by papers focused on Drug Transport and Resistance Mechanisms (13 papers), Cancer therapeutics and mechanisms (13 papers) and Cancer Treatment and Pharmacology (7 papers). Leonard Lothstein collaborates with scholars based in United States, Switzerland and Argentina. Leonard Lothstein's co-authors include Susan Band Horwitz, Trevor W. Sweatman, Mervyn Israel, S Hsu, S. Roy, Jerome Parness, Peter B. Schiff, James J. Manfredi, Wilfredo Mellado and R Zeheb and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Leonard Lothstein

37 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leonard Lothstein United States 20 978 890 187 164 124 37 1.6k
Dale Grabowski United States 22 1.1k 1.1× 650 0.7× 128 0.7× 106 0.6× 67 0.5× 67 1.4k
Douglas C. Marchion United States 23 1.8k 1.8× 609 0.7× 104 0.6× 253 1.5× 131 1.1× 66 2.3k
Richard D. H. Whelan United Kingdom 23 1.1k 1.1× 579 0.7× 191 1.0× 145 0.9× 40 0.3× 51 1.6k
Amadeo M. Parissenti Canada 24 986 1.0× 482 0.5× 233 1.2× 322 2.0× 63 0.5× 68 1.6k
Edvardas Kaminskas United States 20 1.2k 1.3× 405 0.5× 75 0.4× 256 1.6× 52 0.4× 33 2.1k
Glen S. Germain United States 17 986 1.0× 558 0.6× 44 0.2× 155 0.9× 96 0.8× 30 1.6k
George E. Durán United States 26 958 1.0× 860 1.0× 227 1.2× 263 1.6× 118 1.0× 54 1.7k
Taoufik Ouatas United States 23 866 0.9× 337 0.4× 115 0.6× 185 1.1× 39 0.3× 38 1.8k
Kenneth Steadman United States 16 543 0.6× 611 0.7× 44 0.2× 101 0.6× 174 1.4× 28 1.1k
Peter R. Twentyman United Kingdom 22 787 0.8× 884 1.0× 38 0.2× 107 0.7× 168 1.4× 48 1.5k

Countries citing papers authored by Leonard Lothstein

Since Specialization
Citations

This map shows the geographic impact of Leonard Lothstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonard Lothstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonard Lothstein more than expected).

Fields of papers citing papers by Leonard Lothstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonard Lothstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonard Lothstein. The network helps show where Leonard Lothstein may publish in the future.

Co-authorship network of co-authors of Leonard Lothstein

This figure shows the co-authorship network connecting the top 25 collaborators of Leonard Lothstein. A scholar is included among the top collaborators of Leonard Lothstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonard Lothstein. Leonard Lothstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lothstein, Leonard, Judith E. Soberman, Deanna N. Parke, et al.. (2020). Pivarubicin Is More Effective Than Doxorubicin Against Triple-Negative Breast Cancer In Vivo. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 28(5). 451–465. 2 indexed citations
2.
Mittal, Nivesh, Bivash Mandal, Pavan Balabathula, et al.. (2018). Formulation, Development, and In Vitro Evaluation of a CD22 Targeted Liposomal System Containing a Non-Cardiotoxic Anthracycline for B Cell Malignancies. Pharmaceutics. 10(2). 50–50. 5 indexed citations
3.
Berardi, Damián E., et al.. (2010). Involvement of PKC delta (PKCδ) in the resistance against different doxorubicin analogs. Breast Cancer Research and Treatment. 126(3). 577–587. 24 indexed citations
4.
Cai, Chun, Leonard Lothstein, R. Ray Morrison, & Polly A. Hofmann. (2010). Protection from Doxorubicin-Induced Cardiomyopathy Using the Modified Anthracycline N-Benzyladriamycin-14-valerate (AD 198). Journal of Pharmacology and Experimental Therapeutics. 335(1). 223–230. 26 indexed citations
5.
Du, Ziyun, Meiyun Fan, Jong-Gwan Kim, et al.. (2009). Interferon-resistant Daudi Cell Line with a Stat2 Defect Is Resistant to Apoptosis Induced by Chemotherapeutic Agents. Journal of Biological Chemistry. 284(41). 27808–27815. 25 indexed citations
6.
Hofmann, Polly A., Mervyn Israel, Yoshihiro Koseki, et al.. (2007). N-Benzyladriamycin-14-valerate (AD 198): A Non-Cardiotoxic Anthracycline That Is Cardioprotective through PKC-ϵ Activation. Journal of Pharmacology and Experimental Therapeutics. 323(2). 658–664. 16 indexed citations
7.
He, Yongwen, Jihua Liu, Douglas Grossman, et al.. (2007). Phosphorylation of mitochondrial phospholipid scramblase 3 by protein kinase C‐δ induces its activation and facilitates mitochondrial targeting of tBid. Journal of Cellular Biochemistry. 101(5). 1210–1221. 47 indexed citations
8.
9.
10.
Panta, Ganesh R., Lakita G. Cavin, Christina M. Barrett, et al.. (2004). Circumvention of Nuclear Factor κB-Induced Chemoresistance by Cytoplasmic-Targeted Anthracyclines. Molecular Pharmacology. 65(4). 1038–1047. 19 indexed citations
11.
Lothstein, Leonard, Mervyn Israel, & Trevor W. Sweatman. (2001). Anthracycline drug targeting: cytoplasmic versus nuclear – a fork in the road. Drug Resistance Updates. 4(3). 169–177. 66 indexed citations
12.
Lothstein, Leonard, D. Parker Suttle, J. Brent Roaten, et al.. (2000). Catalytic inhibition of DNA topoisomerase II by N-benzyladriamycin (AD 288). Biochemical Pharmacology. 60(11). 1621–1628. 13 indexed citations
13.
Israel, Mervyn, et al.. (1998). Cellular resistance against the novel hybrid anthracycline N-(2-chloroethyl)-N-nitrosoureidodaunorubicin (AD 312) is mediated by combined altered topoisomerase II and O6-methylguanine-DNA methyltransferase activities.. PubMed. 10(4). 209–17. 6 indexed citations
14.
15.
Lothstein, Leonard, Yoshihiro Koseki, & Trevor W. Sweatman. (1994). P-glycoprotein overexpression in mouse cells does not correlate with resistance to N-benzyladriamycin-14-valerate (AD 198). Anti-Cancer Drugs. 5(6). 623–633. 5 indexed citations
16.
Hsu, Stephen I‐Hong, et al.. (1990). Structural Analysis of the Mouse mdr1a (P-Glycoprotein) Promoter Reveals the Basis for Differential Transcript Heterogeneity in Multidrug-Resistant J774.2 Cells. Molecular and Cellular Biology. 10(7). 3596–3606. 20 indexed citations
17.
Hsu, Stephen I‐Hong, et al.. (1990). Structural analysis of the mouse mdr1a (P-glycoprotein) promoter reveals the basis for differential transcript heterogeneity in multidrug-resistant J774.2 cells.. Molecular and Cellular Biology. 10(7). 3596–3606. 115 indexed citations
18.
Greenberger, Lee M., Leonard Lothstein, R. Scott Williams, & Susan Band Horwitz. (1988). Distinct P-glycoprotein precursors are overproduced in independently isolated drug-resistant cell lines.. Proceedings of the National Academy of Sciences. 85(11). 3762–3766. 80 indexed citations
19.
Lothstein, Leonard, et al.. (1985). General organization of protein in HeLa 40S nuclear ribonucleoprotein particles.. The Journal of Cell Biology. 100(5). 1570–1581. 88 indexed citations
20.
Walker, Barbara, et al.. (1980). The release of 40S hnRNP particles by brief digestion of HeLa nuclei with micrococcal nuclease. Nucleic Acids Research. 8(16). 3639–3658. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dale Grabowski Breakdown of academic impact, for papers by Douglas C. Marchion Breakdown of academic impact, for papers by Richard D. H. Whelan Breakdown of academic impact, for papers by Amadeo M. Parissenti Breakdown of academic impact, for papers by Edvardas Kaminskas Breakdown of academic impact, for papers by Glen S. Germain Breakdown of academic impact, for papers by George E. Durán Breakdown of academic impact, for papers by Taoufik Ouatas Breakdown of academic impact, for papers by Kenneth Steadman Breakdown of academic impact, for papers by Peter R. Twentyman
Rankless by CCL
2026